- Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB-IV NSCLC (LCDigital-IO Study): a multicenter retrospective studyWu, Shaowei; Zhan, Weijie; Liu, Lan; Xie, Daipeng; Yao, Lintong; Yao, Henian; Liao, Guoqing; Huang, Luyu; Zhou, Yubo; You, Peimeng; Huang, Zekai; Li, Qiaxuan; Xu, Bin; Wang, Siyun; Wang, Guangyi; Zhang, Dong-Kun; Qiao, Guibin; Chan, Lawrence Wing-Chi; Lanuti, Michael; Zhou, Haiyu*Journal for ImmunoTherapy of Cancer, 2023, 11(10): e007369.
- Intratumoral heterogeneity as a predictive biomarker in immunotherapy for advanced non-small cell lung cancer.Xiao, HaiPing; Chen, Kai; Zheng, Yating; Huang, MengliAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.
- A Novel Multiparameter Biomarker of Pathological Response for NSCLC Receiving Neoadjuvant Immunotherapy: A Real-world StudyWu, S.; Zhou, H.; Zhan, W.
会议论文
Pretreatment radiomic biomarker for immunotherapy responder prediction in IB-IV stage NSCLC: A multi-center retrospective study
7阅读
